Arcturus Therapeutics Holdings Inc. (ARCT) financial statements and ratios from SEC XBRL: revenue $82.03M (TTM), net margin -80.2%, revenue growth -46.1% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $82.03M |
| Net Margin | -80.2% |
| Revenue Growth (YoY) | -46.1% |
| EPS Growth (YoY) | -20.0% |
| FCF Growth (YoY) | 23.4% |
| Price / Book | 2.23 |
| Price / Sales | 15.78 |
| FCF Yield | -35.7% |
| Altman Z-Score | 1.64 (distress) |
| Sector P/E (Healthcare) | 21.7 |
ARCT overview · ARCT earnings · ARCT KPIs · ARCT investor relations · ARCT ownership · ARCT peers · ARCT filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.